Related references
Note: Only part of the references are listed.Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019
Dave Singh et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Sputum Microbiome Is Associated with 1-Year Mortality after Chronic Obstructive Pulmonary Disease Hospitalizations
Fernando Sergio Leitao Filho et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Phenotyping and outcomes of hospitalized COPD patients using rapid molecular diagnostics on sputum samples
Nawaf M. Alotaibi et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2019)
Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study
Zhang Wang et al.
THORAX (2018)
Genetic mannose binding lectin deficiency is associated with airway microbiota diversity and reduced exacerbation frequency in COPD
Alison J. Dicker et al.
THORAX (2018)
Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease
Alison J. Dicker et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles
Michael A. Ghebre et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
David A. Lipson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Blood eosinophil levels as a biomarker in COPD
Guy Brusselle et al.
RESPIRATORY MEDICINE (2018)
Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations
David Mayhew et al.
THORAX (2018)
The effect of changes to GOLD severity stage on long term morbidity and mortality in COPD
Robert W. V. Flynn et al.
RESPIRATORY RESEARCH (2018)
Precision medicine in airway diseases: moving to clinical practice
Alvar Agusti et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD
Marco Cantoli et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
Claus F. Vogelmeier et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
The microbiome in respiratory medicine: current challenges and future perspectives
Rosa Faner et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Extracellular eosinophilic traps in association with Staphylococcus aureus at the site of epithelial barrier defects in patients with severe airway inflammation
Elien Gevaert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice
James D. Chalmers et al.
NPJ PRIMARY CARE RESPIRATORY MEDICINE (2017)
Lung microbiome dynamics in COPD exacerbations
Zhang Wang et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Treatable traits: toward precision medicine of chronic airway diseases
Alvar Agusti et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis
Ian D. Pavord et al.
LANCET RESPIRATORY MEDICINE (2016)
Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function
Mona Bafadhel et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2015)
Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials
Steven Pascoe et al.
LANCET RESPIRATORY MEDICINE (2015)
The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial
Geraint B. Rogers et al.
LANCET RESPIRATORY MEDICINE (2014)
Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study
MeiLan K. Han et al.
LANCET RESPIRATORY MEDICINE (2014)
Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD
Davinder S. Garcha et al.
THORAX (2012)
Acute Exacerbations of Chronic Obstructive Pulmonary Disease Identification of Biologic Clusters and Their Biomarkers
Mona Bafadhel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Chronic Obstructive Pulmonary Disease Phenotypes The Future of COPD
MeiLan K. Han et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study
C. Garcia-Vidal et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials
Leonardo M. Fabbri et al.
LANCET (2009)
Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease
Gary P. Anderson
LANCET (2008)
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
JJ Soler-Cataluña et al.
THORAX (2005)
Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis
AT Hill et al.
AMERICAN JOURNAL OF MEDICINE (2000)
Share Paper
